1. Bai Z, Wang L, Yu B, et al. Efficacy and safety of tranexamic acid in the treatment of gastric cancer complicated with upper gastrointestinal bleeding. Am J Transl Res. 2024;16(3):925-932. doi:10.62347/KOLI5819
2. Tantoro AF, Tarigan RB, Rianti KI, Indra S. Outcomes of Tranexamic Acid Treatment in Patients with Upper Gastrointestinal Bleeding: An Overview of Reviews. Acta Medica Indonesiana, 2026. 58(2), 138. https://actamedindones.org/index.php/ijim/article/view/3009
3. Harnshaw S, Logan R, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut. 2011;2011(60):654-62.
4. Syam A, Abdullah M, Makmun D, et al. The Causes of Upper Gastrointestinal Bleeding in the National Referral Hospital: Evaluation on Upper Gastrointestinal Tract Endoscopic Result in Five Years Period. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 2005.
5. Cook DJ, Griffith LJ, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Critical Care. 2001;5(6):368-75.
6. Satapathy S, Sanyal A. Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterology Clinics of North America. 2014;2014(43):819-33.
7. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
8. Chertoff J, Lowther G, Alnuaimat H, Ataya A. The Use of Tranexamic Acid for Upper Gastrointestinal Bleeding by Medical and Surgical Intensivists: A Single Center Experience. Gastroenterology Research. 2017;10(4):235-7.
9. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;2012(344):e3054.
10. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105-16.
11. Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum harmorrhage. Cochrane Database of Systemic Reviews 2015, Issue 6. Art. No.: CD007872. DOI: 10.1002/14651858.CD007872.pub3.
12. Eghbali A, Melikof L, Taherahmadi H, Bagheri B. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial. Haemophilia. 2016 Sep;22(5):e423-6. doi: 10.1111/hae.13051.
13. The HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10241):1927-36.
14. Bennett C, Klingenberg S, Langholz E, Gluud L. Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Systematic Review. 2014;2014(11):CD006640.
15. Calderon Martinez E, Briceño Silva GD, et al. Tranexamic acid as treatment for acute gastrointestinal bleeding: A comprehensive systematic review and meta-analysis. Indian J Gastroenterol. 2025 Jun;44(3):311-329. doi: 10.1007/s12664-025-01749-9.
16. Kumar M, Venishetty S, Jindal A, et al. Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis: A randomized controlled trial. Hepatology. 2024 Aug 1;80(2):376-388. doi: 10.1097/HEP.0000000000000817.
17. Lisman T. Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis. Seminars in Thrombosis and Hemostasis. 2017;43(2):178-84.
18. O'Donnell O, Gallagher C, Davey MG, Coulter J, Regan M. A systematic review and meta-analysis assessing the use of tranexamic acid (TXA) in acute gastrointestinal bleeding. Ir J Med Sci. 2024;193(2):705-719. doi:10.1007/s11845-023-03517-0